Article Information
History
- October 26, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Moïse Michel1,2,*,#,
- Fabrice Malergue3,*,
- Inès Ait Belkacem3,
- Pénélope Bourgoin3,
- Pierre-Emmanuel Morange4,
- Isabelle Arnoux4,
- Tewfik Miloud3,
- Matthieu Million1,2,
- Hervé Tissot-Dupont2,
- Jean-Louis Mege1,2,
- Jean-Marc Busnel3 and
- Joana Vitte1,2
- 1Aix-Marseille Univ, IRD, APHM, MEPHI, Marseille, France
- 2IHU Méditerranée Infection, Marseille, France
- 3Beckman Coulter, Marseille, France
- 4C2VN Aix Marseille Univ INSERM, INRAE, APHM Hôpitaux Universitaires de Marseille, Hôpital Timone, Service d’hématologie, Marseille, France
- ↵#Corresponding author:
Dr. Moïse Michel, Unité d’immuno-allergologie, IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005 Marseille, France, moise0michel{at}gmail.com, Phone : +33413732051
↵* MM and FM contributed equally to the paper
Posted October 26, 2020.
An ultra-sensitive, ultra-fast whole blood monocyte CD169 assay for COVID-19 screening
